Brainomix 360 Stroke imaging was utilized to improve and standardize the grading of baseline stroke severity, prior to treatment in patients enrolled in Argenica Therapeutic's Phase II study of neuroprotective ARG-007 Brainomix AI core lab uses regulatory cleared stroke technology,...
Hence then, the article about brainomix ai technology reveals efficacy of novel neuroprotective drug candidate in severe acute ischemic stroke patients was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Brainomix AI Technology Reveals Efficacy of Novel Neuroprotective Drug Candidate in Severe Acute Ischemic Stroke Patients )
Also on site :
- Fossil fuel giant wins $370 million tax break for burning gas as an ‘alternative fuel’
- JinkoSolar's Subsidiary, Jinko Solar Co., Ltd., Announces Certain Preliminary Unaudited Financial Results for Full Year 2025
- Elisa and Elisa Industriq join MWC Barcelona 2026, showcasing innovations in energy optimization, autonomous networks, scam prevention, and more